Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exicure Inc (XCUR)

Exicure Inc (XCUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Exicure Inc 400 Seaport Court Suite 102 Redwood City CA 94063 USA

www.exicuretx.com Employees: 7 P: 847-673-1700 F: 847-556-6411

Sector:

Medical

Description:

Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.

Key Statistics

Overview:

Market Capitalization, $K 33,973
Enterprise Value, $K 21,463
Shares Outstanding, K 6,374
Annual Sales, $ 500 K
Annual Net Income, $ -9,700 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,440 K
EBIT, $ -9,540 K
EBITDA, $ -8,720 K
60-Month Beta 4.08
% of Insider Shareholders 52.80%
% of Institutional Shareholders 42.82%
Float, K 3,008
% Float 47.20%
Short Volume Ratio 0.25

Growth:

1-Year Return -78.02%
3-Year Return 50.14%
5-Year Return -98.21%
5-Year Revenue Growth -61.54%
5-Year Earnings Growth 93.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.39 on 11/07/25
Next Earnings Date 11/13/25
Earnings Per Share ttm -4.64
EPS Growth vs. Prev Qtr 4.88%
EPS Growth vs. Prev Year 31.58%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 08/28/24

XCUR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -177.55%
Return-on-Assets % -86.42%
Profit Margin % -1,940.00%
Debt/Equity 0.00
Price/Sales 62.46
Price/Cash Flow N/A
Price/Book 6.15
Book Value/Share 1.10
Interest Coverage -483.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar